Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 109 Lymphoma 108 Lymphoma, Non-Hodgkin 104 Leukemia, Lymphocytic, Chronic, B-Cell 86 Lymphoma, Large B-Cell, Diffuse 78 Lymphoma, Follicular 67 Burkitt Lymphoma 52 Hodgkin Disease 51 Multiple Myeloma 49 Lymphoma, B-Cell 47 Lymphoma, Mantle-Cell 45 Recurrence 41 Leukemia, Myeloid, Acute 41 Leukemia 40 Neoplasms 30 Hematologic Neoplasms 30 Myelodysplastic Syndromes 27 Lymphoma, B-Cell, Marginal Zone 23 Waldenstrom Macroglobulinemia 22 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 18 Lymphoma, T-Cell 17 Leukemia, B-Cell 17 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 16 Sarcoma 14 Lymphoma, T-Cell, Peripheral 14 Lymphoma, Large-Cell, Anaplastic 14 Leukemia, Biphenotypic, Acute 12 Mycosis Fungoides 11 Melanoma 11 Lymphoma, T-Cell, Cutaneous 10

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Large B-cell Lymphoma × Lymphoid × 30 days × Clear all

NCT07215585 2026-05-22

SOUNDTRACK-D2

AstraZeneca

Phase 3 Recruiting

Large B-cell Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡